IKT — INHIBIKASE THERAPEUTICS INC

Ownership history in Commodore Capital LP  ·  5 quarters on record

This page tracks every 13F SEC filing in which Commodore Capital LP reported a position in INHIBIKASE THERAPEUTICS INC (IKT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.41% (2024 Q4)
Avg. % of fund
0.84%
First filed
2024 Q4
Last filed
2025 Q4
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 5,397,488 — 0% 0.74% $11.1M $2.05
2025 Q3 UNCHANGED 5,397,488 — 0% 0.43% $8.7M $1.62
2025 Q2 ADDED 5,397,488 +53,056 +1.0% 0.74% $10.5M $1.95
2025 Q1 REDUCED 5,344,432 -580,568 -9.8% 0.86% $11.7M $2.19
2024 Q4 INITIATED 5,925,000 — — 1.41% $19.3M $3.25
% of Fund (quarterly)    IKT price (monthly, adj. close)

Other funds also holding IKT

As of 2025 Q4 — sorted by position size

Sands Capital Alternatives, LLC 3Y 5.15% Stonepine Capital Management, LLC 3Y 7Y 3.51% Saturn V Capital Management LP 3Y 1.45% CAXTON CORP 3Y 7Y 1.36% Fairmount Funds Management LLC 3Y 1.35% ADAR1 Capital Management, LLC 1.2% Seven Fleet Capital Management LP 0.83% Soleus Capital Management, L.P. 3Y 0.82% Exome Asset Management LLC 0.59% Siren, L.L.C. 0.36%
← Back to Commodore Capital LP Holdings